ELAVL1 and laryngotracheoesophageal cleft: We developed a risk prognostic signature consisting of ZC3H13, CBLL1, ELAVL1 and YTHDF1 in 1039 LC patients from TCGA dataset as the training set by Lasso cox analysis and GEO dataset as the verified set.